Products

What will AGI do for Acitretin?

This classification denotes a retinoic acid agent with the molecular formula C21H26O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LCH760E9T7, chemically known as 2,4,6,8-nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-e)- but generally known as acitretin, which bears US NIH Compound Identifier 5284513. European Medicines Agency schedules Acitretin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05240MIG. The term ACITRETIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 1, No. 4, 1987, List 27). World Health Organization schedules acitretin in its Anatomical Therapeutic Chemical (ATC) Classification. ACITRETIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule acitretin under HS 29189900 and SITC 51396. As of Q4 2014, ACITRETIN remains the US FDA Preferred Term for this commodity. Acitretin bears US NLM identifiers UMLS ID C0678135 and NCI Concept Code C985. SMILES: O(C1C(C(C(C(C1)C)/C=C/C(=C/C=C/C(=C/C(=O)O)C)C)C)C)C.